共 11 条
[1]
Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence[J] . Brian R Dulin,Henry Krum.Current Opinion in Cardiology . 2006 (4)
[5]
The implications of a growing evidence base for drug use in elderly patients. Part 3.?β‐adrenoceptor blockers in heart failure and thrombolytics in acute myocardial infarction[J] . A. A.Mangoni,S. H. D.Jackson.British Journal of Clinical Pharmacology . 2006 (5)
[6]
Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)[J] . Lawrence Baruch,Robert D. Glazer,Nora Aknay,Johan Vanhaecke,J. Thomas Heywood,Inder Anand,Henry Krum,Allen Hester,Jay N. Cohn.American Heart Journal . 2004 (6)
[7]
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients[J] . The Lancet . 2000 (9215)
[8]
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure[J] . Milton Packer,Philip A. Poole-Wilson,Paul W. Armstrong,John G.F. Cleland,John D. Horowitz,Barry M. Massie,Lars Rydén,Kristian Thygesen,Barry F. Uretsky.Circulation . 1999 (23)
[9]
Heart Failure With Normal Ejection Fraction: The V-HeFT Study[J] . Jay N. Cohn,Gary Johnson.Circulation . 1990 (2 Su)
[10]
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. Taylor AL,Ziesche S,Yancy C, et al. New England Journal of Medicine, The . 2004